Genome‐defined African ancestry is associated with distinct mutations and worse survival in patients with diffuse large B‐cell lymphoma-Reference-Cited by-同舟云学术

Genome‐defined African ancestry is associated with distinct mutations and worse survival in patients with diffuse large B‐cell lymphoma

Published:2020-05-29 Issue:15 Volume:126 Page:3493-3503
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Lee Michelle J.¹²^ORCID,Koff Jean L.³^ORCID,Switchenko Jeffrey M.⁴^ORCID,Jhaney C. Ileen³,Harkins R. Andrew¹,Patel Sharvil P.³,Dave Sandeep S.⁵,Flowers Christopher R.³⁶^ORCID

Affiliation:

1. Emory University School of Medicine Atlanta Georgia USA

2. Department of Medicine Morehouse School of Medicine Atlanta GeorgiaUSA

3. Department of Hematology and Medical Oncology Winship Cancer Institute Emory University Atlanta Georgia USA

4. Department of Biostatistics and Bioinformatics Emory University Atlanta Georgia USA

5. Center for Genomic and Computational Biology Duke Cancer Institute Duke University Durham North Carolina USA

6. Department of Lymphoma and Myeloma The University of Texas MD Anderson Cancer Center Houston Texas USA

Funder

Winship Cancer Institute

V Foundation for Cancer Research

Burroughs Wellcome Fund

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.32866

Reference49 articles.

1. 2016 US lymphoid malignancy statistics by World Health Organization subtypes

2. Improving Outcomes for Patients With Diffuse Large B-Cell Lymphoma

3. Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d'Etudes des Lymphomes de l'Adulte

4. Diagnosis-to-Treatment Interval Is an Important Clinical Factor in Newly Diagnosed Diffuse Large B-Cell Lymphoma and Has Implication for Bias in Clinical Trials

5. Progression-free survival at 24 months (PFS24) and subsequent outcome for patients with diffuse large B-cell lymphoma (DLBCL) enrolled on randomized clinical trials

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association between low incidence of TP53 mutations and reduced early relapse rates in Uygur DLBCL;Annals of Hematology;2024-08-27

2. Non-Hodgkin lymphoma mortality disparities across different sexes, races, and geographic locations;Journal of Investigative Medicine;2024-07-24

3. Axi-cel outcomes among non-Hispanic Black patients;Blood;2024-06-27

4. Disparity in hematological malignancies: From patients to health care professionals;Blood Reviews;2024-05

5. The impact of race and ethnicity on diffuse large B-cell lymphoma outcomes within the veterans health administration (VHA);Leukemia & Lymphoma;2024-04-15